Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

Journal of Molecular Neuroscience

Volumn 17, Issue 3, 2001, Pages 311-324

  Karacay, Bahri ^a   Wilkening, Bahri ^a   Hollenback, Clay ^a   Kasow, Kim ^b   Krahe, Ralf ^c  

^a UNIVERSITY OF IOWA   (United States)

^b Division of Virology Department of Infectious Diseases St Jude Children's Hospital   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

cDNA; Expression; Mapping; Mouse; VPAC1

Indexed keywords

COMPLEMENTARY DNA; PROTEIN VPAC1; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; BRAIN; CANCER INHIBITION; CEREBELLUM; CHROMOSOME 3P; CHROMOSOME 8Q; CHROMOSOME 9; COLON; FLUOROMETRY; FOREBRAIN; HETEROZYGOSITY LOSS; HUMAN; MOLECULAR CLONING; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL CULTURE TECHNIQUES; CHROMOSOME MAPPING; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TRANSFECTION;

ANIMALIA; MURINAE;

EID: 0035704785     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:17:3:311     Document Type: Article

References (82)

1. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor
2. VIP, PACAP, and related peptides second international symposium
3. Intestinal secretion: Stimulation by peptides
4. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts
5. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation
6. Adrenal vasoactive intestinal peptide participates in neonatal corticosteroid production in the rat
7. Vasoactive intestinal peptide and electrical activity influence neuronal survival
8. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen
9. Identification and immunohistochemistry of cholinergic and non-cholinergic circular muscle motor neurons in the guinea-pig small intestine
10. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP
11. 1 receptor
12. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes
13. A physical map of 30,000 human genes
14. Chromosomal assignment of 11 loci in the ratby mouse-rat somatic hybrids and linkage
15. Vasoactive intestinal peptide stimulates testosterone production by cultured fetal rat testicular cells
16. Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase
17. Prevention of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I
18. Expression of vasoactive intestinal peptide receptors in central and peripheral primitive neuroectodermal tumors of childhood
19. Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells
20. Projections of substance P, vasoactive intestinal peptide and tyrosine hydroxylase immunoreactive nerve fibres in the canine intestine, with special reference to the innervation of the circular muscle
21. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs
22. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN-γ from stimulated murine T lymphocytes
23. Molecular genetic changes found in human lung cancer and its precursor lesions
24. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
25. VIP: Molecular biology and neurobiological function
26. A new concept in the pharmacology of neuroprotection
27. Acylation of viral and eukaryotic proteins
28. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
29. A radiation hybrid map of the human genome
30. International union of pharmacology XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
31. Genomic organization and chromosomal location of the mouse vasoactive intestinal polypeptide 1 (VPAC1) receptor
32. Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow
33. The distribution of vasoactive intestinal peptide in the rat adrenal cortex and medulla
34. An STS-based map of the human genome
35. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
36. Enhancement by vasoactive intestinal peptide of γ-interferon production by antigen-stimulated type 1 helper T cells
37. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA
38. Biochemical characterization of cellular hormone receptors
39. Comitogenic effects of vasoactive intestinal polypeptide on rat hepatocytes
40. Regulation of vasoactive intestinal peptide receptor expression in developing nervous system
41. Structural features in eukaryotic mRNAs that modulate the initiation of translation
42. Selective gene expression and activation-dependent regulation of VIP type 1 (VPAC1) and type 2 (VPAC2) in human T-cells
43. Effects of vasoactive intestinal peptide (VIP) on the testicular vasculature of the rat
44. 2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
45. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: A possible regulatory mechanism for the local control of energy metabolism
46. Glycoproteins
47. Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo
48. VIP inhibits the proliferation of small-cell and non-small-cell lung carcinoma
49. Efficient high-resolution genetic mapping of mouse interspersed repetitive sequence PCR products, toward integrated genetic and physical mapping of the mouse genome
50. Definition of a tumor suppressor locus within human chromosome 3p21-22
51. Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC
52. Projections of chemically-specified neurons in the guinea-pig colon
53. LIGAND: A versatile computerized approach for the characterization of ligand binding systems
54. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: Evidence for difference in the structure-function relationship
55. Vasoactive intestinal peptide: Autocrine growth factor in neuroblastoma
56. Characterization of the VIP receptor in rat frontal cortex
57. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: Relevance to neuroprotection in Parkinson's disease
58. Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets
59. Genomic structure and embryonic expression of the rat type 1 vasoactive intestinal polypeptide receptor gene
60. In vitro differentiation of human neuroblastoma cells caused by vasoacrive intestinal peptide
61. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
62. Casein kinase 2: An 'eminence grise' in cellular regulation
63. Effects on smooth muscle preparations of unidentified vasoactive peptides from intestine and lung
64. Vasoactive intestinal peptide
65. Pathways of inflammation and cell death in the lung: Modulation by vasoactive intestinal peptide
66. Polypeptide with broad biological activity: Isolation from small intestine
67. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene
68. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor
69. A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat
70. Gene-based anchoring of the rat genetic linkage and cytogenetic maps: New regional localizations, orientation of the linkage groups, and insights into mammalian chromosome evolution
71. The biology and enzymology of eukaryotic protein acylation
72. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
73. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments
74. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism
75. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: Progress toward the isolation of a lung cancer TSG
76. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC)
77. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)
78. Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements
79. PACAP stimulates glucose output from the perfused rat liver
80. Vasoactive intestinalpolypeptide receptor binding sites in the human gastrointestinal tract: Localization by autoradiography